Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening
Lung CancerThis study is part of the development and validation of a non-invasive lung screening test which aim to identify early stage lung cancer in patients at high risk for lung cancer.
null
Participation Requirements
-
Sex:
ALL -
Eligible Ages:
50 to 80
Participation Criteria
Inclusion Criteria - Cases:
* Current or past smokers, with at least 20 pack-years
* Subjects with either A high suspicion for lung cancer, with planned surgery to establish a definitive diagnosis within 60 days after date of blood collection OR treatment naive lung cancer patients
Exclusion Criteria - Cases:
* Known diagnosis or treatment of any previous cancer, including lung cancer, in the past 5 years, except for fully resected non-melanoma skin cancer or fully-resected carcinoma in situ of the cervix
* Current lung cancer is known to be stage III or IV by pathology.
Inclusion Criteria - Screening:
- Current or past smokers, with at least 20 pack-years, undergoing LDCT for lung cancer screening
Exclusion Criteria - Screening:
* Known diagnosis or treatment of any cancer, including lung cancer, in the past 5 years, except for fully resected non-melanoma skin cancer or fully-resected carcinoma in situ of the cervix
* Subjects whose purpose of performing LDCT is for surveillance of a lung nodule
Study Location
University Health Network
University Health NetworkToronto, Ontario
Canada
Contact Study Team
Vancouver General Hospital/The University of British Columbia
Vancouver General Hospital/The University of British ColumbiaVancouver, British Columbia
Canada
Contact Study Team
McGill University Health Centre
McGill University Health CentreMontréal, Quebec
Canada
Contact Study Team
University of Calgary
University of CalgaryCalgary, Alberta
Canada
Contact Study Team
- Study Sponsored By
- Nucleix Ltd.
- Participants Required
- More Information
- Study ID:
NCT04968548